NCT00571818 is a NA clinical trial of Oral glucose tolerance test in Transplant, sponsored by University of Nebraska.

Who is sponsoring NCT00571818?

NCT00571818 is sponsored by University of Nebraska.

What drugs are being tested in NCT00571818?

Interventions in NCT00571818: Oral glucose tolerance test, IV Glucose Tolerance Test.

What condition does NCT00571818 study?

NCT00571818 studies Transplant, Diabetes.

Is NCT00571818 still recruiting?

NCT00571818 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT00571818

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients

Completed NA Last updated 10 October 2023

What this trial tests

NA trial testing Oral glucose tolerance test in Transplant in 31 participants. Completed in 1 June 2010.

Timeline

1 November 2000

Primary endpoint
1 March 2008

1 June 2010

Quick facts

Lead sponsor	University of Nebraska
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	factorial
Masking	none
Primary purpose	diagnostic
Enrollment	31
Start date	1 November 2000
Primary completion	1 March 2008
Estimated completion	1 June 2010
Sites	1 location across United States

Drugs / interventions tested

Oral glucose tolerance test — full drug profile →
IV Glucose Tolerance Test

Conditions studied

Transplant — all drugs for Transplant →
Diabetes — all drugs for Diabetes →

Sponsor

University of Nebraska

Who can join

Adults 19 to 65, any sex, with Transplant or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand how the pancreas functions after transplantation and particularly why high blood sugar levels develop. It will also analyze the effect of the medicines used to prevent rejection on blood sugar levels. The hypothesis to be tested is that hyperglycemia more than six months after successful pancreas transplant results from a defect in insulin secretion, insulin resistance, or both.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Oral glucose tolerance test

Trials testing the same drug.

NCT06396871 — Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases · recruiting
NCT05568134 — Alternate Measures of Glucose During OGTT Testing for CFRD · completed
NCT05765123 — Gastric Emptying Validation Pilot Study (MRI Val) · completed
NCT05316038 — Metabolic and Infectious Complications Post Belatacept Conversion · unknown
NCT05310292 — A Glucometabolic Evaluation of Patients With Idiopathic Ketotic Hypoglycemia · NA · unknown

Other recruiting trials for Transplant

Currently open trials in the same condition.

NCT03847285 — Immune Function as Predictor of Infectious Complications and Clinical Outcome in Patients Undergoing Solid Organ Transpl · active not recruiting

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00571818 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00571818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing